"X-linked Nuclear Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
ATP-dependent DNA helicase that contains two N-terminal ZINC FINGERS and C-terminal ATP-binding and helicase domains. It functions in the regulation of gene transcription and CHROMATIN REMODELING. ATRX undergoes cell-cycle dependent phosphorylation, which causes it to translocate from the NUCLEAR MATRIX to CHROMATIN; thus, it may change its role from gene regulation during INTERPHASE to ensuring proper chromosome segregation at MITOSIS. Mutations in the ATRX gene are associated with cases of X-LINKED MENTAL RETARDATION co-morbid with ALPHA-THALASSEMIA (ATRX syndrome).
Descriptor ID |
D000075924
|
MeSH Number(s) |
D08.811.399.340.375
|
Concept/Terms |
X-linked Nuclear Protein- X-linked Nuclear Protein
- Nuclear Protein, X-linked
- X linked Nuclear Protein
- RAD54 Homolog Protein
- Homolog Protein, RAD54
- ATRX Protein
|
Below are MeSH descriptors whose meaning is more general than "X-linked Nuclear Protein".
Below are MeSH descriptors whose meaning is more specific than "X-linked Nuclear Protein".
This graph shows the total number of publications written about "X-linked Nuclear Protein" by people in this website by year, and whether "X-linked Nuclear Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "X-linked Nuclear Protein" by people in Profiles.
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
-
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28; 164(3):550-63.
-
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget. 2015 Oct 06; 6(30):30295-305.
-
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. 2012 Jul; 3(7):709-22.